Literature DB >> 295090

Geographical variation in the incidence of the leukemias and lymphomas.

N S Weiss.   

Abstract

Despite the incomparability in the reporting of leukemia and lymphoma incidence among populations and the relative rarity of these diseases, real differences in rates are discernible from available data. In general, the incidence of each of the leukemias and lymphomas is lower in Japan than in other Pacific rim populations whose rates are known. Particularly striking is the low incidence of CLL in Japan. Among Japanese in Hawaii, rates of some of these cancers (lymphosarcoma, CML) approach those of whites, whereas rates of other cancers (Hodgkin's disease, multiple myeloma, ALL, CLL, and AML) more closely resemble those of native Japanese. The number of Chinese living in countries served by population-based cancer reporting systems is too small for any firm conclusions to be made about leukemia and lymphoma incidence in this group. The incidence of these diseases in certain other nonwhite Pacific rim residents (i.e., Mexican Americans, blacks, and Maoris) is, by and large, similar to that of whites.

Entities:  

Mesh:

Year:  1979        PMID: 295090

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN: 0083-1921


  6 in total

1.  Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.

Authors:  Susan L Slager; Christine F Skibola; Maria Chiara Di Bernardo; Lucia Conde; Peter Broderick; Shannon K McDonnell; Lynn R Goldin; Naomi Croft; Amy Holroyd; Shelley Harris; Jacques Riby; Daniel J Serie; Neil E Kay; Timothy G Call; Paige M Bracci; Eran Halperin; Mark C Lanasa; Julie M Cunningham; Jose F Leis; Vicki A Morrison; Logan G Spector; Celine M Vachon; Tait D Shanafelt; Sara S Strom; Nicola J Camp; J Brice Weinberg; Estella Matutes; Neil E Caporaso; Rachel Wade; Martin J S Dyer; Claire Dearden; James R Cerhan; Daniel Catovsky; Richard S Houlston
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

2.  Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.

Authors:  Silvana Capalbo; Vincenzo Callea; Caterina Musolino; Patrizia Guglielmo; Giovanni D'Arena; Alberto Fragasso; Cosima Battista; Rosario Giustolisi; Maura Brugiatelli; Vincenzo Liso
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

3.  SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.

Authors:  Takeki Mitsui; Hiromi Koiso; Hirotaka Nakahashi; Akio Saitoh; Hiroaki Shimizu; Takuma Ishizaki; Yoshiyuki Ogawa; Makiko Takizawa; Akihiko Yokohama; Takayuki Saitoh; Takahiro Jinbo; Hidemi Ogura; Hiroshi Handa; Morio Sawamura; Tohru Sakura; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

4.  Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia.

Authors:  Ying-Jung Huang; Ming-Chung Kuo; Hung Chang; Po-Nan Wang; Jin-Hou Wu; Yen-Min Huang; Ming-Chun Ma; Tzung-Chih Tang; Ching-Yuan Kuo; Lee-Yung Shih
Journal:  Br J Haematol       Date:  2019-06-23       Impact factor: 6.998

5.  Search for an aetiological virus candidate in chronic lymphocytic leukaemia by extensive transcriptome analysis.

Authors:  Natalia Rego; Sergio Bianchi; Pilar Moreno; Helena Persson; Anders Kvist; Alvaro Pena; Pablo Oppezzo; Hugo Naya; Carlos Rovira; Guillermo Dighiero; Otto Pritsch
Journal:  Br J Haematol       Date:  2012-04-10       Impact factor: 6.998

6.  Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.

Authors:  Dalemari Crowther-Swanepoel; Peter Broderick; Maria Chiara Di Bernardo; Sara E Dobbins; María Torres; Mahmoud Mansouri; Clara Ruiz-Ponte; Anna Enjuanes; Richard Rosenquist; Angel Carracedo; Jesper Jurlander; Elias Campo; Gunnar Juliusson; Emilio Montserrat; Karin E Smedby; Martin J S Dyer; Estella Matutes; Claire Dearden; Nicola J Sunter; Andrew G Hall; Tryfonia Mainou-Fowler; Graham H Jackson; Geoffrey Summerfield; Robert J Harris; Andrew R Pettitt; David J Allsup; James R Bailey; Guy Pratt; Chris Pepper; Chris Fegan; Anton Parker; David Oscier; James M Allan; Daniel Catovsky; Richard S Houlston
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.